These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5023691)

  • 1. Resistance to non-strain-specific variant tumor cells by H-2 allogeneic mice receiving strain-specific cells.
    Forman J; Ketchel MM
    J Natl Cancer Inst; 1972 Apr; 48(4):933-9. PubMed ID: 5023691
    [No Abstract]   [Full Text] [Related]  

  • 2. The PLL gene and histocompatibility genotype in inbred and random-bred guinea pigs.
    Ellman L; Green I; Benacerraf B
    J Immunol; 1971 Aug; 107(2):382-8. PubMed ID: 5568769
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of an immunoresistant and an immunosusceptible ascites subline from murine tumor TA3. II. Immunosensitivity and antibody-binding capacity in vitro, and immunogenicity in allogeneic mice.
    Friberg S
    J Natl Cancer Inst; 1972 May; 48(5):1477-89. PubMed ID: 4113156
    [No Abstract]   [Full Text] [Related]  

  • 4. An MHC-compatible allogeneic bone marrow donor with a distinct role of T cell subsets in graft-versus-leukemia effect and lethal graft-versus-host disease.
    Aizawa S; Kamisaku H; Sado T
    Bone Marrow Transplant; 1995 Oct; 16(4):603-9. PubMed ID: 8528179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-versus-leukemia effect in allogeneic bone marrow transplantation in mice against several radiation-induced leukemias.
    Aizawa S; Sado T; Kamisaku H; Nemoto K; Yoshida K
    Bone Marrow Transplant; 1994 Feb; 13(2):109-14. PubMed ID: 8205078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid and allogeneic resistance to T cell grafts mediated by murine NK and CD8+ T cells.
    Davenport C; Haile A; Kumar V; Bennett M
    J Immunol; 1995 Mar; 154(6):2568-77. PubMed ID: 7876533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
    Schirrmacher V
    Invasion Metastasis; 1981; 1(1):4-21. PubMed ID: 7188381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Strain-specific antigens detected on murine tumour cells by means of rabbit heteroantisera (author's transl)].
    García-Olivares E; Garrido F; Gutiérrez F; Osorio C
    Rev Esp Fisiol; 1979 Jun; 35(2):153-7. PubMed ID: 314651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.
    Zeis M; Uharek L; Glass B; Vosskötter W; Dreger P; Schmitz N; Steinmann J
    Exp Hematol; 1998 Oct; 26(11):1068-73. PubMed ID: 9766447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression in a murine B cell leukemia (BCL1): role of an adherent cell in the suppression of primary in vitro antibody responses.
    Anderson SA; Isakson PC; Puré E; Muirhead M; Uhr JW; Vitetta ES
    J Immunol; 1981 Apr; 126(4):1603-7. PubMed ID: 6451649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
    Henderson LA; Ciavarra R; Riblet R; Forman J
    J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloimmunization for induction of graft-versus-leukemia reactivity in H-2-compatible donors: critical role for incompatibility of donor and alloimmunizing strains at non-H-2 loci.
    Bortin MM; Truitt RL; Shih CY; Tempelis LD; LeFever AV; Rimm AA
    Transplant Proc; 1983 Dec; 15(4):2114-7. PubMed ID: 6673211
    [No Abstract]   [Full Text] [Related]  

  • 13. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
    Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
    Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.
    Ting CC; Rodrigues D
    J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of syngeneic, allogeneic and xenogeneic complement with murine leukaemia and carcinoma cells in vitro [proceedings].
    Peeters P; Verloes R; Atassi G; Kanarek L
    Arch Int Physiol Biochim; 1979 Oct; 87(4):836-8. PubMed ID: 93935
    [No Abstract]   [Full Text] [Related]  

  • 16. Histocompatibility typing of inbred mice for known non-H-2 alleles.
    Graff RJ; Snell GD
    Transplant Proc; 1969 Mar; 1(1):362-4. PubMed ID: 4944240
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of T cell homing by down-regulation of CD62L and the induction of a Th-2 response as a method to prevent acute allograft rejection in mice.
    Stremmel C; Sienel W; Eggeling S; Passlick B; Slavin A
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):362-9. PubMed ID: 16828564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity and in vivo correlates of alloantigen-specific murine suppressor T cells induced by allogeneic pregnancy.
    Nagarkatti PS; Clark DA
    J Immunol; 1983 Aug; 131(2):638-43. PubMed ID: 6223087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute rejection of interferon-treated leukemia cells injected into lethally irradiated syngeneic mice.
    Neri M; Zei T; Tentori L; Bonmassar E; Affabris E; Iorio AM
    Nat Immun; 1993; 12(6):302-15. PubMed ID: 7505668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. III. Control of host resistance to drug-resistant L1210 sublines by H-2-linked and non-H-2-linked genes.
    Fuji H; Murakami M
    J Natl Cancer Inst; 1983 Jan; 70(1):119-25. PubMed ID: 6296515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.